Boehringer Ingelheim's Lung Cancer Drug Shows 'Groundbreaking' Promise in Clinical Trial
2025-04-30
Reuters
In a significant breakthrough for lung cancer treatment, Boehringer Ingelheim has announced “unprecedented” results from a recent clinical trial of their investigational drug. The findings, reported by Reuters, have sent ripples of excitement throug ...Read more
